More info
Active ingredients
Camphor + Salicylic Acid + Turpentine Gum + Poison Gyurza
Release form
Ointment
Composition
1 ml of the preparation contains: Active substance: 0.05% Xylometazoline hydrochloride 0.5 mg Excipients: Benzalkonium chloride 0.15 mg Disodium edetate dihydrate (Trilon B) 0.5 mg Sodium hydrophosphate dihydrate 3.54 mg Potassium dihydrogen phosphate 3.63 mg Sodium chloride 9.0 mg Water for injection up to 1 ml
Pharmacological effect
Viprosal In - irritant remedy of plant origin. Provides irritant and analgesic effect. Causes irritation of sensitive receptors of the skin and subcutaneous tissue, dilates blood vessels, improves tissue trophism.
Indications
Neuralgia, arthralgia, myositis.
Contraindications
skin diseases (including allergic and purulent); active pulmonary tuberculosis; feverish conditions; total exhaustion; severe cerebral and coronary circulation; tendency to angiospasm; severe abnormal liver function; severe renal impairment; pregnancy; lactation (breastfeeding); hypersensitivity to the drug.
Use during pregnancy and lactation
Contraindicated.
Dosage and administration
Viprosal B is used externally. The ointment is applied to the skin of the painful areas 1 time a day at a dose of 5-10 g (1-2 teaspoons) in parts and rubbed into the skin, with severe pain, 2 times a day until the pain syndrome disappears. The course of treatment is on average 10 days. After applying the ointment, wash your hands thoroughly to avoid ointment in the eyes and other mucous membranes.
Side effects
Allergic reactions: in rare cases - skin manifestations - itching, swelling, or urticaria.
Overdose
No data.
Interaction with other drugs
No data.
special instructions
Viprosal ointment should be avoided on open wounds and mucous membranes.